AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ICRA Limited, the Monitoring Agency, has confirmed that Dr. Agarwal's Health Care has used its IPO proceeds in line with the objects stated in the prospectus, with no deviations. Of the Rs. 300 crore fresh issue, Rs. 257 crore has been utilized as of June 30, 2025, leaving Rs. 43 crore unutilized. The full Rs. 195 crore earmarked for debt repayment has been deployed, and Rs. 49.656 crore of the Rs. 77.466 crore general corporate purpose (GCP) allocation has been spent — including Rs. 23.109 crore on acquisitions, Rs. 17.185 crore on medical equipment, and Rs. 7.358 crore on interior works. The remaining Rs. 43 crore is parked in fixed deposits with ICICI Bank (Rs. 25 cr at 5.50%) and Yes Bank (Rs. 18 cr at 6.55%). Both stated objects (debt repayment and GCP) are on schedule with no delays or unfavorable events reported.
This is a routine regulatory compliance filing with clean findings — funds are being deployed exactly as promised to investors at the time of the IPO. No negative impact on the stock; the report reinforces governance transparency and provides comfort that capital raised is being put to productive use.